Claim your 20% discount on Global Market Reports with code ONLINE20. Limited time only.
What Is The Predicted Market Size Of The Biologic Imaging Reagents Industry By 2029?
In past few years, the market size of biologic imaging reagents has witnessed considerable growth. The market which stood at $18.41 billion in 2024 is estimated to rise to $20.1 billion in 2025, representing a compound annual growth rate (CAGR) of 9.1%. The escalation observed in the historical period can be traced back to factors such as increased incidence of chronic diseases, amplified investments in research and development, a transition towards personalized medical treatment, an emphasis on early disease detection, growth in elderly population, and alliances in biomedical research.
Expectations are high for solid expansion in the biologic imaging reagents market, with projections indicating potential growth to $27.49 billion by 2029. This forecast comes with an anticipated compound annual growth rate (CAGR) of 8.1%. The surge in the forecasted period is linked to a multitude of factors. This includes the broadening applications in drug innovation, the growing need for molecular imaging, tendencies towards non-invasive diagnosing procedures, a worldwide upsurge in incidences of cancer, and a shift towards value-based healthcare. Key trends during the forecast period comprise a growing demand for contrast-enhanced imaging agents, advancements in targeted molecular imaging agents, the use of nanoparticles in imaging, the rise of in vivo imaging utilizing fluorescent probes, and the incorporation of artificial intelligence within image analysis.
Get A Free Sample Of The Report:
https://www.thebusinessresearchcompany.com/sample.aspx?id=13389&type=smp
Which Industry Forces Are Driving The Biologic Imaging Reagents Market Forward?
Biological imaging reagents market growth is anticipated to be fueled by the rising prevalence of chronic diseases. Chronic conditions, referring to diseases that persist for a year or longer and necessitate regular medical care, possibly deteriorating over time, often necessitate the use of biological imaging reagents for disease diagnosis and detection through organ and affected structure visualization. For example, the American Cancer Society predicted in 2022 that the total number of new cancer diagnoses and deaths would be 1.9 million and 609,360, respectively, in the United States. Furthermore, the National Library of Medicine projected in January 2023 that the quantity of Americans over 50 years old suffering from at least one chronic disease would surge by 99.5% from 71.522 million to 142.66 million by 2050. The escalating prevalence of chronic diseases is contributing to the expansion of the biological imaging reagents market.
What Is The Segment Breakdown Of The Biologic Imaging Reagents Market?
The biologic imaging reagentsmarket covered in this report is segmented –
1) By Product: Contrast Reagents; Optical Imaging Reagents; Radiopharmaceuticals
2) By Modality: Magnetic Resonance Imaging (MRI); Ultrasound; X-Ray And Computerized Tomography (CT); Nuclear; Optical Imaging; Other Modalities
3) By Application: In Vitro; In Vivo
4) By End User: Diagnostic Laboratories; Imaging Centers; Life Science Companies; Research And Academic Institutes; Other End Users
Subsegments:
1) By Contrast Reagents: X-ray Contrast Agents; MRI Contrast Agents; Ultrasound Contrast Agents
2) By Optical Imaging Reagents: Fluorescent Dyes; Bioluminescent Reagents; Quantum Dots
3) By Radiopharmaceuticals: Diagnostic Radiopharmaceuticals; Therapeutic Radiopharmaceuticals
What New Opportunities Are Emerging From Trends In The Biologic Imaging Reagents Market?
Leading enterprises in the biologic imaging reagents market are turning their attention to the creation of cutting-edge reagents, such as revolutionary dye tech, providing a fresh instrument for researchers and clinicians to enhance the sensitivity and specificity of biologic imaging. This latest dye technology involves the invention of new dyes for a variety of purposes, one of them being biological imaging. For example, in April 2022, Becton, Dickinson, and Company, a medical device firm from the United States, unveiled BD Horizon RealYellow 586 Reagents and RealBlue Reagents. This new reagent suite enables researchers to obtain more detailed data and glean more understanding from samples compared to the usual fluorochrome, courtesy of the use of groundbreaking dye technology and the oversight of artificial intelligence (AI). The AI evaluated existing data from the excitation and emission profiles of commercially available fluorochromes and subsequently pinpointed the optimal spots in laser lines for the creation of innovative dyes.
Which Companies Are Contributing Significantly To The Biologic Imaging Reagents Market Growth?
Major companies operating in the biologic imaging reagents market report are Cardinal Health Inc., Johnson And Johnson Services Inc., Bayer Healthcare AG, Thermo Fisher Scientific Inc., Siemens Healthcare GmbH, Dickinson and Company (BD), Koninklijke Philips N.V., GE HealthCare Technologies Inc., Stryker Corporation, FluoroPharma Medical Inc., Lonza Group AG, Illumina Inc., PerkinElmer Inc., Becton, Dickinson and Company, Bio-Rad Laboratories Inc., Bracco Diagnostics Inc., Leica Microsystems GmbH, Lantheus Medical Imaging Inc., Guerbet SA, Miltenyi Biotec B.V. and Co. KG, Promega Corporation, Abcam plc., Luminex Corporation, MILabs, LI-COR Biosciences, FUJIFILM VisualSonics Inc., Advanced Proteome Therapeutics Incorporated, BIOPRO Baden-Württemberg GmbH, ABX Advanced Biochemical Compounds GmbH
Access The Complete Report Here:
https://www.thebusinessresearchcompany.com/report/biologic-imaging-reagents-global-market-report
Which Region Is Leading Innovation In The Biologic Imaging Reagents Market?
North America was the largest region in the biologic imaging reagents market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the biologic imaging reagents market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
Customize Your Report Here:
https://www.thebusinessresearchcompany.com/customise?id=13389&type=smp
Browse Through More Reports Similar to the Global Biologic Imaging Reagents Market 2025, By The Business Research Company
Bioabsorbable Stents Global Market Report 2025
https://www.thebusinessresearchcompany.com/report/bioabsorbable-stents-global-market-report
Bioinformatics Global Market Report 2025
https://www.thebusinessresearchcompany.com/report/bioinformatics-global-market-report
Biophotonics Global Market Report 2025
https://www.thebusinessresearchcompany.com/report/biophotonics-global-market-report
About The Business Research Company:
With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.
Get in touch with us:
The Business Research Company: https://www.thebusinessresearchcompany.com/
Americas +1 310-496-7795
Asia +44 7882 955267 & +91 8897263534
Europe +44 7882 955267
Email us at info@tbrc.info
Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model